The Acting Chief Health Officer of NSW, Dr Tony Penna has advised today that GlaxoSmithKline (GSK) has initiated a retail level recall of 10 batches of Ventolin and Asmol Inhalers due to a fault in the delivery mechanism leading to an inconsistent dose. In devices that are affected, the dose of the active medication - salbutamol - may not be delivered in full. In some cases, approximately one third of the normal dose may be delivered per puff of the inhaler.
“People who use Ventolin or Asmol inhalers should check the batch number to see if the inhaler they are using is affected by the recall. To confirm the relevant batch number, remove the canister from the plastic tube and the batch number will be found is on the bottom of the canister label. If they identify that they have one of the affected inhalers, it can be returned to their pharmacy for a free replacement,” Dr Penna said.
"Should people using the affected batches of Ventolin or Asmol inhalers experience a worsening of their asthma or have concerns about the use of their inhaler they are advised to seek immediate medical attention."
Batches affected are:
This batch recall does not affect any other delivery forms of Ventolin and Asmol or other respiratory medicines.
“Due to limited access to medical services over the Christmas and New Years period, asthma sufferers and their carers should also ensure that they know what medical services are available over the coming week,” Dr Penna advised.
For more information visit TGA - Ventolin and Asmol (salbutamol) CFC-free MDI 100 mcg/200 doses inhalers (certain batches only).